Diagnosis and Management of Testicular Cancer The European Point of
This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper f
- PDF / 3,695,040 Bytes
- 136 Pages / 439.42 x 683.15 pts Page_size
- 19 Downloads / 164 Views
123
Diagnosis and Management of Testicular Cancer
Susanne Krege Editor
Diagnosis and Management of Testicular Cancer The European Point of View
Editor Susanne Krege Kliniken Essen-Mitte Klinik für Urologie Essen Germany
ISBN 978-3-319-17466-2 ISBN 978-3-319-17467-9 DOI 10.1007/978-3-319-17467-9
(eBook)
Library of Congress Control Number: 2015941277 Springer Cham Heidelberg New York Dordrecht London © Springer International Publishing Switzerland 2015 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper Springer International Publishing AG Switzerland is part of Springer Science+Business Media (www. springer.com)
Contents
Part I
1
Latest Recommendations of the European Germ Cell Cancer Group on Diagnosis and Treatment of Germ Cell Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Susanne Krege
Part II
2
Overview of the Latest Recommendations of the European Germ Cell Cancer Group
3
Special Topics About Controversial Aspects, New Results from Studies, Which Might Change Treatment Recommendations and Long-Term-Survivorship
Is There Still an Indication for Radiotherapy in Seminoma Clinical Stages I–IIA/B? . . . . . . . . . . . . . . . . . . . . . . . . Sophie Dorothea Fosså and Klaus-Peter Dieckmann
19
3
How Should We Treat Clinical Stage I (CSI) Nonseminoma . . . . . . Torgrim Tandstad
4
Is There Still an Indication for Primary RPLND in Clinical Stage I Non-seminoma? . . . . . . . . . . . . . . . . . . . . . . . . . . . Nicola Nicolai and Alessandro Crestani
29
Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category . . . . . . . . . . . . . . . . . . . . Carsten Bokemeyer and Christoph Seidel
55
5
6
Poor-Prognosis Germ Cell Tumours . . . . . . . . . . . . . . . . . . . . . . . . . . Karim Fizazi and Stephane Culine
7
How Should Patients with Recurrent Disease Be Treated Actually? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Anja Lorch
25
65
73
v
vi
8
9
1
Data Loading...
